HighMark Wealth Management LLC
Top Portfolio Positions
428 positions ·
$85,097,235 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| AXGN |
Axogen, Inc.
Healthcare
|
344,940 | $11,427,862 | 13.43% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
236,785 | $9,405,100 | 11.05% | |
| WFC |
Wells Fargo & Company/Mn
Financial Services
|
68,597 | $5,461,007 | 6.42% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
94,050 | $5,216,013 | 6.13% | |
| NEO |
Neogenomics Inc
Healthcare
|
579,834 | $4,302,368 | 5.06% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
83,720 | $2,388,531 | 2.81% | |
| NVDA |
Nvidia Corp
Technology
|
12,775 | $2,227,960 | 2.62% | |
| SIBN |
SI-BONE, Inc.
Healthcare
|
159,832 | $2,018,678 | 2.37% | |
| AAPL |
Apple Inc.
Technology
|
7,840 | $1,989,713 | 2.34% | |
| MASS |
908 Devices Inc.
Healthcare
|
319,350 | $1,954,422 | 2.30% |
Portfolio Trend
25 quarters · across all stocks
Holdings in ANAB
Shares Held
Position Value (USD)
5 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,216,013 | 94,050 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,559,544 | 94,050 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,135,231 | 135,050 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,231,210 | 145,550 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,710,280 | 92,000 | Shares | Sole | 2025-04-24 | |
| No 13F history on record for this holder in this stock. | ||||||